Nasdaq

ARS Pharmaceuticals Announces FDA Approval of neffy® 1 mg, First Needle-Free Epinephrine Treatment for Children Ages 4 and Up

neffy 1 mg is the first approved needle-free epinephrine nasal spray for children aged 4 to 30 kg, addressing severe allergic reactions. ARS Pharmaceuticals announced the FDA approval of neffy 1 mg, ...
AOL

What It's Like To Try The First At-Home, Needle-Free Flu Vaccine

Back-to-school season is an exciting time of year, but it’s also the start of something no one likes: flu season. And in case you didn't already know: The top science-backed way to lower your risk of ...
Yahoo

FDA approves first non-needle treatment for severe allergic reactions

Add Yahoo as a preferred source to see more of our stories on Google. On August 9 the U.S. Food and Drug Administration (FDA) announced it had approved an epinephrine spray for emergency treatment of ...
The Washington Post

FDA approves needle-free alternative to EpiPen for allergic reactions

A newly approved nasal spray for serious allergic reactions will serve as a critical alternative to EpiPens and other auto-injectors, helping to treat such reactions quicker in people who are afraid ...
AOL

The first needle-free flu shot, delivered right to your door

This flu season, there’s a new way to protect yourself and your family—without booking an appointment, sitting in a waiting room, or bracing for a needle. FluMist, a nasal spray vaccine that has been ...
FOX8 Cleveland

FDA approves first needle-free alternative to treat dangerous allergic reactions

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. (AP) – U.S. health officials on Friday ...